Results for &quot;&quot;Zanamivir&quot;&quot;[mesh_terms]

Sialidase Inhibitors with Different Mechanisms.

Joseph M Keil, Garrett R Rafn, Isaac M Turan, Majdi A Aljohani, Reza Sahebjam-Atabaki, Xue-Long Sun

Journal of medicinal chemistry 2022;65(20):13574-13593

Virus susceptibility analyses from a phase IV clinical trial of inhaled zanamivir treatment in children infected with influenza.

Phillip J Yates, Nalini Mehta, Joseph Horton, Margaret Tisdale

Antimicrobial agents and chemotherapy 2013;57(4):1677-84

Clinical outcome of laninamivir octanoate hydrate for influenza in the 2013-2014 Japanese season.

Hideyuki Ikematsu, Naoki Kawai, Norio Iwaki, Seizaburo Kashiwagi

Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy 2016;21(11):802-7

Anti-influenza viral effects of honey in vitro: potent high activity of manuka honey.

Ken Watanabe, Ratika Rahmasari, Ayaka Matsunaga, Takahiro Haruyama, Nobuyuki Kobayashi

Archives of medical research 2014;45(5):359-65

Safety of the long-acting neuraminidase inhibitor laninamivir octanoate hydrate in post-marketing surveillance.

Seizaburo Kashiwagi, Sanae Yoshida, Hiroki Yamaguchi, Shinpei Niwa, Noriko Mitsui, Masatoshi Tanigawa, Kazuhito Shiosakai, Naoki Yamanouchi, Tomoo Shiozawa, Fumie Yamaguchi

International journal of antimicrobial agents 2013;40(5):381-8

Neuraminidase inhibitors for the treatment and prevention of influenza.

Jennifer L McKimm-Breschkin

Expert opinion on pharmacotherapy 2002;3(2):103-12

Lessons learned from the 2007-2008 cold and flu season: what worked and what was worthless.

Mark A Moyad, Larry E Robinson

Urologic nursing 2008;28(2):146-8, 145

Continued effectiveness of laninamivir octanate hydrate for influenza treatment in Japan: comparison between the 2011-2012 and 2012-2013 influenza seasons.

Hideyuki Ikematsu, Naoki Kawai, Norio Iwaki, Seizaburo Kashiwagi

Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy 2015;20(12):799-803

Molecular basis of drug resistance in A/H1N1 virus.

Ariela Vergara-Jaque, Horacio Poblete, Eric H Lee, Klaus Schulten, Fernando González-Nilo, Christophe Chipot

Journal of chemical information and modeling 2013;52(10):2650-6

Exploring the mechanism of zanamivir resistance in a neuraminidase mutant: a molecular dynamics study.

Nanyu Han, Xuewei Liu, Yuguang Mu

PloS one 2013;7(9):e44057

Duration of fever and other symptoms after the inhalation of laninamivir octanoate hydrate; comparison of the 2011/12 to 2015/16 Japanese influenza seasons.

Hideyuki Ikematsu, Naoki Kawai, Norio Iwaki, Seizaburo Kashiwagi

Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy 2018;23(9):627-633

Efficacy and Safety of Nitazoxanide in Addition to Standard of Care for the Treatment of Severe Acute Respiratory Illness.

Ana E Gamiño-Arroyo, M Lourdes Guerrero, Sean McCarthy, Alejandra Ramírez-Venegas, Beatriz Llamosas-Gallardo, Arturo Galindo-Fraga, Sarbelio Moreno-Espinosa, Yuri Roldán-Aragón, Javier Araujo-Meléndez, Sally Hunsberger, Violeta Ibarra-González, Julia Martínez-López, Luis A García-Andrade, Heather Kapushoc, H Preston Holley, Mary C Smolskis, Guillermo M Ruiz-Palacios, John H Beigel

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2020;69(11):1903-1911

The duration of fever and other symptoms after the initiation of laninamivir octanoate hydrate in the Japanese 2011-2012 influenza season.

Hideyuki Ikematsu, Naoki Kawai, Norio Iwaki, Seizaburo Kashiwagi

Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy 2014;20(2):81-5

Influenza therapy.

James W Myers

Southern medical journal 2003;96(8):744-50